Health care costs are skyrocketing, and it's a bitter pill to swallow for millions of Americans. The latest premium hikes have left many feeling like they're being priced out of their own health coverage. But why are these increases happening, and who's to blame?
Let's dive into the complex world of health insurance and explore the factors driving up costs.
The Premium Pain Point: A Nation's Affordability Crisis
Workers, Obamacare enrollees, and Medicare beneficiaries are all facing steeper-than-usual premium increases for 2026. This is just another layer of stress in an already challenging affordability landscape.
Employers are bracing for a 9% rise in health benefit costs, the largest increase in several years. While they aim to cushion the blow for their employees, the impact is still significant. Premiums for the benchmark Affordable Care Act plan have soared by an average of 26%, one of the biggest jumps since the Obamacare plans began over a decade ago. And with the expiration of enhanced federal subsidies, enrollees can expect their premium payments to spike by a whopping 114% on average, according to KFF.
Medicare Part B premiums, covering doctors' visits and outpatient services, have also seen a substantial increase of nearly 10% this year, the largest in four years and the second-largest hike in the program's history. The standard monthly premium is now $202.90, up from $185 last year, as reported by the Centers for Medicare and Medicaid Services.
But here's where it gets controversial...
The Insurer's Role: Coordination vs. Cost Control
Insurers are under scrutiny in Washington, with President Donald Trump planning to meet with industry leaders to pressure them into lowering premiums. Meanwhile, House lawmakers grilled several major insurer CEOs in daylong hearings.
Representatives from both sides of the political aisle challenged the executives, questioning their ability to control costs, especially given their growing dominance in the healthcare market. Lawmakers accused insurers of prioritizing profits over patient care by denying or delaying treatment approvals.
The insurers argue that their multi-service provider model allows for better treatment coordination and value-focused care. They also point out that they are legally required to spend at least 80% of premium dollars on healthcare claims. Additionally, they are reforming their prior authorization practices to streamline the approval process.
However, Vivian Ho, a health economist at Rice University, suggests that insurers may not always feel the pressure to reduce costs. For instance, when larger employers hire an insurance company to administer their health benefits but pay their workers' claims, the incentive to negotiate aggressively is reduced.
Common Factors Driving Up Costs
While each market segment (employer, Medicare, and Affordable Care Act) has its specific reasons for premium increases, there are several common factors at play.
One major factor is the increased utilization of healthcare services. Americans have been visiting doctors more frequently in recent years and receiving more intensive treatments. This trend is partly due to people deferring care during the pandemic, leading to later-stage diagnoses in some cases, according to experts.
For example, since the Covid-19 pandemic, more workers have been accessing mental health services, an area that employers have focused on expanding. In the second quarter of 2025, 10.1% of policyholders had a behavioral health office visit, compared to 7.1% in the same period in 2019, as per a Mercer consulting firm study.
The growth of medical clinics and telehealth providers has also made healthcare more accessible, says Sunit Patel, US chief actuary for health and benefits at Mercer. Additionally, there is a wider range of providers, such as physician assistants, available to treat patients.
Another factor is the rise in chronic diseases among Americans. Obesity, diabetes, heart and lung diseases, cancer, and Alzheimer's disease among the elderly are all on the increase. In 2023, more than three-quarters of American adults had at least one chronic disease, and over half had multiple conditions, as reported in the US Centers for Disease Control and Prevention's journal Preventing Chronic Disease.
Cancer, musculoskeletal conditions, and heart disease are the top medical conditions driving up employer costs in recent years, according to a study by the Business Group on Health. Employers are seeing earlier onsets of cancers among younger workers, and diagnoses are often made when the disease is more advanced.
Higher prices, particularly for hospital care, are also contributing to premium increases. Hospitals, like insurers, have been merging and acquiring other medical service providers, including doctors' offices, outpatient facilities, and labs. In 2023, nearly half of metropolitan areas had inpatient care controlled by one or two health systems, according to KFF. And in 2024, 55% of physicians were employed by hospitals.
Hospital consolidation has led to higher prices, and hospital acquisitions of physician practices also tend to drive up costs, as per a 2022 RAND study. Health systems often add facility fees or other charges when patients visit doctor offices or other outpatient providers they own.
Many health systems also have pricing leverage by insisting that all their hospitals be included in an insurer's network, even across different regions. This puts pressure on employers and insurance companies, who want reasonably broad networks, to agree to these terms.
The American Hospital Association, when asked for comment, pointed to a statement released for one of the House hearings, highlighting consolidation in the insurance market and its impact on premiums and costs.
The Cost of Innovation: Pharmaceutical Advances
The development of innovative medications for obesity and diabetes has come at a high price. The share of very large firms covering GLP-1 drugs for obesity soared to 43% in 2025, up from 28% the previous year, according to KFF's annual Employer Health Benefits Survey. Nearly 60% of large firms reported higher-than-expected usage of these medications for weight loss, with two-thirds saying the impact on prescription drug spending was significant.
Several insurers on the Affordable Care Act exchanges cited obesity drugs as a factor in premium increases for 2026. At least one insurer, Blue Cross Blue Shield of Massachusetts, has decided to discontinue coverage of these medications for weight loss in 2026, which will reduce premiums by about 3%.
GLP-1 drugs are not the only culprits. Expensive cancer treatments, gene therapies, and other medications are also contributing to premium hikes. Higher projected spending on physician-administered drugs, such as chemotherapy, is a major reason for the increase in Medicare Part B costs, according to Medicare's trustees.
When asked for comment, a leading pharmaceutical industry trade group, PhRMA, responded by saying that insurers are trying to shift the blame by linking rising premiums to higher medicine costs. PhRMA points to CMS data showing hospital prices rising more than twice as fast as retail pharmaceutical prices since 2007, arguing that hospital care is where costs are most out of control.
So, what's your take on the rising health insurance costs? Do you think insurers are doing enough to control costs, or is the healthcare system itself at fault? Share your thoughts in the comments below!
